SEI Investments’s Protara Therapeutics TARA Stock Holding History

SEI Investments’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-63,079	Closed	-$336K	–	3328
2025 Q4	$336K	Buy	+63,079	New	+$351K	﹤0.01%	2679

Other funds holding TARA

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SEI Investments's TARA Position: Q1 2026 in Review

SEI Investments sold out of Protara Therapeutics (TARA) in Q1 2026, closing a stake of 63,079 shares — an estimated $336K sold.

SEI Investments first reported a position in TARA in Q4 2025 and held it in 1 quarter. The position peaked at $336K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

SEI Investments reported no remaining Protara Therapeutics position as of Q1 2026 after selling out during the quarter.
SEI Investments sold 63,079 Protara Therapeutics shares in Q1 2026, an estimated $336K.
SEI Investments first reported a position in Protara Therapeutics in Q4 2025 and held it in 1 quarter.
SEI Investments's Protara Therapeutics position peaked at $336K in Q4 2025.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.